4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-22-035106
Director sold 10,000 shares at $33.71 ($337,069)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZASLOFF MICHAEL A Director | 2022-03-16 | Option exercise | +10,000 | $17.11 | $171,100 | 57,206 | D |
| ZASLOFF MICHAEL A Director | 2022-03-16 | Sale | −10,000 | $33.71 | $337,069 | 47,206 | D |
| Derivatives | |||||||
| ZASLOFF MICHAEL A Director | 2022-03-16 | Option exercise · Stock Option (right to buy) | −10,000 | 10,291 | D | ||
| Open-market sales · 10,000 sh · avg $33.71 · $337,069 | |||||||
Loading xslF345X03/tm227973-10_4seq1.xml…